日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma.

建立和验证用于定量分析人血浆中法匹拉韦的LC-MS/MS方法

Challenger Elizabeth, Penchala Sujan Dilly, Hale Colin, Fitzgerald Richard, Walker Lauren, Reynolds Helen, Chiong Justin, Fletcher Tom, Khoo Saye, Else Laura

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

β-d-N4-羟基胞苷(前药莫努匹拉韦的母核苷)在重症急性呼吸综合征冠状病毒2感染患者非血浆隔室中的药代动力学

FitzGerald, Richard; Dickinson, Laura; Else, Laura; Fletcher, Thomas; Hale, Colin; Amara, Alieu; Walker, Lauren; Penchala, Sujan Dilly; Lyon, Rebecca; Shaw, Victoria; Greenhalf, William; Bullock, Katie; Lavelle-Langham, Lara; Reynolds, Helen; Painter, Wendy; Holman, Wayne; Ewings, Sean; Griffiths, Gareth; Khoo, Saye

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019

献血者中 HIV 暴露前或暴露后预防 (PrEP/PEP) 的证据:一项试点研究,英国,2018 年 6 月至 2019 年 7 月

Harvala, Heli; Reynolds, Claire; Ijaz, Samreen; Maddox, Vicki; Penchala, Sujan Dilly; Amara, Alieu; Else, Laura; Brailsford, Susan; Khoo, Saye

Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma

开发、验证和应用一种高灵敏度的液相色谱-串联质谱法(LC-MS/MS)定量分析人血浆中皮下植入剂释放的左炔诺孕酮

Cirrincione, Lauren R; Penchala, Sujan Dilly; Scarsi, Kimberly K; Podany, Anthony T; Winchester, Lee C; Back, David J; Khoo, Saye H; Fletcher, Courtney V; Siccardi, Marco; Else, Laura J

Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk

验证和临床应用一种新型液相色谱-质谱联用方法定量测定母乳中的多替拉韦

Gini, Joshua; Penchala, Sujan Dilly; Amara, Alieu; Challenger, Elizabeth; Egan, Deirdre; Waitt, Catriona; Lamorde, Mohammed; Orrell, Catherine; Myer, Landon; Khoo, Saye; Else, Laura J

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant

依非韦伦(而非奈韦拉平)类抗逆转录病毒疗法会降低皮下植入避孕器释放的左炔诺孕酮的暴露量。

Scarsi, Kimberly; Lamorde, Mohammed; Darin, Kristin; Penchala, Sujan Dilly; Else, Laura; Nakalema, Shadia; Byakika-Kibwika, Pauline; Khoo, Saye; Cohn, Susan; Merry, Concepta; Back, David